Media formats available:
Recommended
- Lp(a), a new lipid frontier in CV risk management & target for therapyIntroduction: Lp(a), a new lipid frontier in CV risk management & target for therapy
Prof. Erik Stroes, MD
- Lp(a), a new lipid frontier in CV risk management & target for therapyIs there a role for PCSK9 inhibition in patients with high Lp(a)?
Prof. Vera Bittner, MD
- Lp(a), a new lipid frontier in CV risk management & target for therapyNovel strategies to lower Lp(a)
Prof. Sam Tsimikas